Individuals with chronic kidney disease (CKD) are more likely to die of cardiovascular causes than progress to end-stage renal disease. A recent report on a large, contemporary cohort highlights the high rates of CKD among patients with acute coronary syndromes, the poor outcomes associated with CKD, and the ongoing gap between evidence and practice in this population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).
Anavekar, N. S. et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 351, 1285–1295 (2004).
Winkelmayer, W. C., Levin, R. & Setoguchi, S. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin. J. Am. Soc. Nephrol. 3, 1415–1422 (2008).
Fox, C. S. et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 121, 357–365 (2010).
Chertow, G. M., Normand, S. L. & McNeil, B. J. “Renalism”: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J. Am. Soc. Nephrol. 15, 2462–2468 (2004).
Coca, S. G., Krumholz, H. M., Garg, A. X. & Parikh, C. R. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296, 1377–1384 (2006).
Shlipak, M. G. et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann. Intern. Med. 137, 555–562 (2002).
Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238–248 (2005).
Fellstrom, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395–1407 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rifkin, D., Sarnak, M. Absence of evidence or evidence of absence? ACS treatment in CKD. Nat Rev Nephrol 6, 449–450 (2010). https://doi.org/10.1038/nrneph.2010.82
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2010.82
